Alumni Fellows

Alumni Fellows

Square crop for person placeholder (250x250)

2021 - 2022

Tatiana Bujnoch, Pharm.D.

Tatiana Bujnoch, Pharm.D., earned her Pharm.D. from Northeastern University and her Master of Science in pharmacy administration and leadership from the University of Houston. She completed a Health System Pharmacy Administration and Leadership residency at Memorial Hermann Health System in Houston. 

She was selected as the 2021-2022 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow. She completed her congressional placement on the Health Subcommittee within House Ways and Means.

In her current role, she serves as an Associate for External Affairs at Morgan Health.

Headshot of Nimit Jindal, Pharm.D.

2020 - 2021

Nimit Jindal, Pharm.D.

Nimit Jindal earned his Pharm.D. from the Ernest Mario School of Pharmacy at Rutgers and completed his PHY-1 Community-Based Pharmacy Residency at Moose Pharmacy through the UNC Eshelman School of Pharmacy. Jindal also served as the Piscataway Township Ward 4 Elected Committeeman, where he engaged with elected members of the local and state governments to develop policy solutions to infrastructure and educational funding concerns. This and other opportunities he’s had to learn about and influence policy changes fueled his decision to pursue this fellowship.

He was selected as the 2020-2021 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow. He completed his congressional placement on the Senate Committee on Health, Education, Labor and Pensions (HELP) within the office of the ranking member Sen. Patty Murray.

He currently serves as a Health and Labor Legislative Assistant to Congressman Joseph Morelle (D-NY).

Kyle Robb headshot

2019 - 2020

Kyle Robb, Pharm.D.

Kyle Robb is a 2013 graduate of the Eshelman School of Pharmacy at the University of North Carolina and previously served as a pharmacist at the University of Virginia Health System in Charlottesville from 2013-19. During his tenure at UVA, Robb gained extensive experience in hospital pharmacy practice, transitions of care, population health, specialty pharmacy and health system administration. Robb became a Board Certified Pharmacotherapy Specialist in 2016.

He was selected as the 2019-20 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow where he served on the staff of the Senate Committee on Health, Education, Labor and Pensions (HELP) within the office of the ranking member Sen. Patty Murray. His responsibilities included researching and writing briefs on a wide array of health care issues, assisting with policy analyses, drafting policy memos, meeting with constituents, selecting panelists for congressional hearings, and writing committee talking points and questions for panelists. His issue portfolio included surprise medical billing, opioids, drug pricing and health insurance exchange markets.

In his current role, he serves as the State Policy & Advocacy Associate at the American Society of Health-System Pharmacists.

Tina Chhabra headshot

2018 - 2019

Tina Chhabra, Pharm.D.

Tina Chhabra earned her Doctor of Pharmacy degree in 2016 from the Virginia Commonwealth University School of Pharmacy before completing a post-doctoral fellowship in regulatory sciences and safety and benefit-risk management through the MCPHS University Biopharmaceutical Industry Fellowship Program at Biogen, Inc.

She was selected for the 2018-2019 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow Program. She obtained placement in the office of Senator Sherrod Brown (D-OH) and worked on a variety of legislative and health care policy issues.

Nellie Jafari headshot

2017 - 2018

Nilofar Jafari, Pharm.D.

Nellie Jafari earned her bachelor's degree in psychology from the University of Virginia and her Doctor of Pharmacy degree from Virginia Commonwealth University School of Pharmacy. Upon graduation from pharmacy school, she completed a PGY1/PGY2 Health System Pharmacy Administration Residency with Allegheny General Hospital, part of the Allegheny Health Network, while completing a Master of Public Health and a Health Systems Leadership Management Certificate at the University of Pittsburgh. She was selected for the 2017-18 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow Program.

She obtained placement in the United States Senate with the personal office of Senator Chris Murphy (D-CT) and worked on a variety of legislative and healthcare policy issues including drug shortages, prescription drug pricing, the opioid epidemic, mental health and health care reform.

Upon completion of the fellowship, she joined Booz Allen Hamilton in their military health division and worked on contracts for the Defense Health Agency and the Veterans Affairs Office of Electronic Health Record Modernization.

In December 2020, Jafari joined the Department of Veterans Affairs where she serves as a program manager for the Pharmacy Benefits Management Clinical Informatics Office.


2016 - 2017

Mary Abdelmalak, Pharm.D.

Mary Abdelmalak was a community pharmacist with Rite Aid in Cleveland, Ohio. A native of Egypt, she moved to the United States at age 12. Abdelmalak earned her bachelor’s degree in biology and philosophy from John Carroll University and her Pharm.D. from The Ohio State University College of Pharmacy. She also completed a PGY1 Community Care Pharmacy Practice Residency at Ohio State. Her areas of interest in health policy include the correlation between behavioral/mental health policy, economic/social legislation and health outcomes as well as preventive medicine policies, population health analysis and access determination.

Abdelmalak’s Congressional Healthcare Policy Fellow experiences, which began July of 2016, included a week with the Brookings Institution and three weeks at ACCP with Edwin Webb, associate executive director, and John McGlew, director of government affairs. Following three weeks with ASHP’s Office of Policy, Planning and Communications, under the mentorship of Joe Hill of the government affairs staff, she began her placement with the office of Senator Charles “Chuck” Grassley of Iowa, who sits on the Senate Finance; Budget; Judiciary; and Agriculture, Nutrition and Forestry.


2015 - 2016

Rita (Habib) Livadas, Pharm.D.

Rita Livadas earned her Doctor of Pharmacy degree in 2013 from Rutgers University at the Ernest Mario School of Pharmacy. During that time, she interned at Robert Wood Johnson University Hospital, developing an interest in health system pharmacy. She was also involved in several policy and advocacy efforts on local, state, and federal levels and served as the regional delegate for the American Pharmacists Association’s Academy of Student Pharmacists in addition to being president of the Phi Lambda Sigma chapter at Rutgers.

Upon graduation, she moved to Pittsburgh to pursue a PGY1/PGY2 Health System Pharmacy Administration residency with Allegheny General Hospital, part of the Allegheny Health Network. During that time, she also completed a Master of Public Health at the University of Pittsburgh. The residency program provided her with the opportunity develop leadership and pharmacy management skills in information technology, finance, business strategy, medication safety and clinical program development.

In September and October of 2015 she completed the association component of the fellowship with ASHP and ACCP. In November, she began her placement with the office of Sen. Michael F. Bennet from Colorado, who sits on the Senate Finance; Health, Education, Labor, and Pensions; as well as Agriculture, Nutrition and Forestry committees. During her time with Senator Bennet, she worked on legislation that was included in the Senate Biomedical Innovation Package as well as priorities in the Senate Finance Committee Bipartisan Chronic Care Working Group.

Livadas currently serves as director of Public Affairs for BD.


2014 - 2015

Tracy Rupp, Pharm.D.

As a Congressional Healthcare Policy Fellow, Tracy Rupp obtained placement in the office of Sen. Robert P. Casey, Jr. (D-PA). In this capacity, she worked on health policy issues involving the FDA, NIH, Medicare, and Medicaid, providing research and analysis on various topics, including antibiotic resistance, opioid abuse, maternal and child health, drug and device regulation, and health information technology.

She is currently a consumer safety officer in the Division of Compounding Policy and Outreach within the Office of Compounding Quality and Compliance at the FDA. In this role, Rupp works on compounding policy development and stakeholder communication. Early in her pharmacy career, she worked as a hospital pharmacist, specializing in nutrition support services.

Rupp holds both Doctor of Pharmacy and Master of Public Health degrees from the University of North Carolina at Chapel Hill. She completed a PGY1 pharmacy residency at WakeMed Health and Hospitals in Raleigh, NC, and is a board certified pharmacotherapy specialist and registered dietitian.


2013 - 2014

Daniel Nam, J.D.

Daniel Nam worked as a pharmacist in Morgan Stanley Children's Hospital of New York until 2013. Prior to that, in 2008, he started a community pharmacy in a culturally diverse neighborhood. It was while operating the pharmacy that he realized his passion for policy development, specifically concerning minority health care. As a result, he enrolled in law school, where he advocated for health care rights for seniors and indigent clients (New York Legal Assistance Group), externed at the NYS Attorney's General Office (Medicaid Fraud Unit, Hauppauge, NY), interned with the government affairs division in the National Community Pharmacists Association, and campaigned for a congressional race. Nam graduated law school in 2013 and started his Congressional Healthcare Policy Fellowship a short time later.

During the year-long Congressional Healthcare Policy Fellowship, he worked in the personal office of Sen. Michael F. Bennet. There, he staffed on legislative and policy issues, which heavily included staffing health care issues from the U.S. Senate H.E.L.P. and Finance Committees. He also worked heavily with Colorado state constituents on various health care and child welfare issues. During the fellowship, Nam was able to gain valuable insight and experience regarding politics, policy-making and effective legislating.

After the fellowship, he joined the Defense and Intelligence Group of the government consulting firm, Booz Allen Hamilton. There, he worked on DoD health care contracts, including the MHS 90 Day Follow On and Operation Live Well contracts. As part of the Operation Live Well contract, he gained consulting and project management skills by leading the Analytics and the Congressional Report teams. He then served as the associate principal for Pharmacy Policy at Avalere Health. He currently serves as Vice President of Policy at the Global Liver Institute. Follow him on Twitter @danieljnam.

2012 - 2013

Derek Griffing, Pharm.D.

Derek Griffing received his Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health and his Doctor of Pharmacy degree from the Chicago College of Pharmacy at Midwestern University. He was a pharmacist at Johns Hopkins Hospital prior to beginning the fellow program.

As the 2012-13 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow, Griffing spent one month with the government affairs division at both ACCP and ASHP, and in November, he attained a position as a health policy fellow on Capitol Hill in the office of Sen. Sheldon Whitehouse (Rhode Island).

Griffing was responsible for staffing Senator Whitehouse at Senate Health, Education, Labor, and Pensions (HELP) Committee hearings and meetings. In this capacity, he led his office on compounding pharmacy legislation that was developed in response to the 2012 fungal meningitis outbreak. He managed stakeholder concerns, helped develop policies to protect public health and participated in bipartisan negotiations. Griffing also wrote speeches for Senator Whitehouse and was responsible for keeping the senator up to speed on numerous health care delivery system reforms in the Affordable Care Act.

After completing the fellow program, he accepted a position as a research associate in the Center for Health Policy at the Brookings Institution in Washington, D.C. In this role, he managed multiple projects related to improving regulatory science, evidence development and innovation in medical products in the United States. Griffing is currently a policy analyst in the Office of Generic Drug Policy at the United States Food and Drug Administration. In this position, he conducts research on a broad range of legal and regulatory issues and is supporting the FDA in the its efforts to renegotiate the Generic Drug User Fee Amendments of 2012. He is also an adjunct professor at Georgetown University.


2011 - 2012

Sarah Steinhardt, Pharm.D.

Sarah Steinhardt earned her Doctor of Pharmacy degree with distinction in 2003 from the Purdue University College of Pharmacy in West Lafayette, Indiana.

While at Purdue, she completed her Pharm.D. project by performing a pharmacy compounding experiment in simulated microgravity conditions at NASA’s Johnson Space Center in Houston, Texas.

After graduation, she practiced retail pharmacy for more than six years combined at a Wal-Mart in Kokomo and Walgreens in both Crawfordsville and Rensselaer, Indiana, and enrolled in the Indiana University Robert H. McKinney School of Law, where she obtained her J.D. in 2009 with a concentration inhealth law.

While in law school, she served as a note development editor for the Indiana Health Law Review, was named to the Order of the Barristers in the Robert H. Stanton Intramural Moot Court Competition, and was selected as an associate justice for the Moot Court Board.

She then completed a PGY2 pharmacy management residency at the University of Pittsburgh Medical Center and obtained a Master of Science in Pharmacy Administration. During her residency, she gained experience in pharmacy and clinical operations, hospital staffing, medication safety, and leadership, as well as obtaining a Mastery of Teaching certification.

In 2011, she was selected to be the ACCP/ASHP/VCU Congressional Healthcare Policy Fellow. Initially, she worked within the government affairs divisions of ACCP and ASHP before obtaining placement in the United States Senate in the personal office of Senator Ron Wyden, where she enjoyed working with the senator and staff on a portfolio of drug crime and judiciary issues.

She is currently an assistant professor at the University of South Florida in Tampa, where she teaches the Jurisprudence course and an elective on Drugs of Abuse, Addiction, & Law Enforcement. She was voted P3 Teacher of the Year for 2014-2015. You can contact her at


2010 - 2011

Joshua Paul Lorenz, Pharm.D.

Joshua Lorenz earned his Doctor of Pharmacy and Master of Business Administration degrees at Butler University in Indianapolis. Upon graduation, he was selected as a PGY1 Ambulatory Care Pharmacy Practice Resident at The Ohio State University College of Pharmacy. He worked on an interdisciplinary team to help manage chronic diseases for patients at the Columbus Neighborhood Health Center, a group of federally qualified health centers with a multicultural population.

As the fourth Congressional Healthcare Policy Fellow, Lorenz obtained placement in the U.S. Senate Committee for Health, Education, Labor, and Pensions under ranking member Senator Enzi. His work included involvement with multiple divisions within HHS, including the FDA, CMS and the NIH. In addition to working during the beginning of implementation of the Affordable Care Act, Lorenz's legislative portfolio involved drug shortages (FDA Safety and Innovation Act), user fees for generic pharmaceutical manufacturers (GDUFA), and Medicare Part D updates. He also currently sits on the Ohio Pharmacist Association Legal and Regulatory Committee.

Lorenz is currently a clinical assistant professor at the James L. Winkle College of Pharmacy at the University of Cincinnati in Cincinnati. Prior to his current position at the University of Cincinnati, he moved from Washington, D.C., to Cincinnati, after being hired as Assurex Health's first Medical Science Liaison. During his time at Assurex Health, he educated hundreds of physicians and nurse practitioners about genomics and pharmacogenomics and how to utilize genetic information in everyday clinical practice to improve the lives of patients. In addition to clinical pharmacogenomics, his areas of interest also include chronic disease management, digital health and health outcomes. He can be reached at and on Twitter @CincyPharmD.


2008 - 2010

Stephanie Hammonds, Pharm.D.

Stephanie Hammonds earned her Doctor of Pharmacy degree in 2004 from Purdue University, where she also pursued a nuclear pharmacy certification and a French minor, created an experiential clerkship rotation at Lilly France (Eli Lilly and Company) in Suresnes, and focused her final project on the differences in pharmacy practice between France and the U.S. Upon graduation, she joined The Johns Hopkins Hospital in Baltimore, Maryland, as a point-of-care pharmacist, focused in pediatric oncology. Additionally, she co-founded the hospital’s Pediatric Pharmacy Safety Committee, and served on the compliance committee to update the hospital’s sterile compounding areas to the United States Pharmacopeial Convention’s chapter 797 standards.

In 2006, Hammonds moved to Brooklyn, New York, to work in the New York Presbyterian – Weill Cornell Medical Center’s surgery pharmacy. She also served as the interim chair of the Legislative Action Committee for the New York City Society of the New York State Council of Health-System Pharmacists and volunteer tutored high school biology and chemistry. In September 2007, she returned to her hometown of York, Pennsylvania, to assist her family in caring for her grandmother while working as a community pharmacist for Target and pursuing graduate coursework in health policy.

In 2008, Hammonds was selected as the ASHP/ACCP/VCU Congressional Healthcare Policy Fellow and obtained placement in the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Majority Health policy office, chaired by senators Kennedy and Harkin (after Senator Kennedy’s death). Her work focused on antimicrobial resistance, global health, and health quality and delivery system improvement initiatives for the national health reform debate. Although she contributed to other sections, she wrote section 3503 of the Patient Protection and Affordable Care Act (P.L. 111-148), Medication Management in the Treatment of Chronic Diseases.

In 2010, she joined the U.S. Department of Health and Human Services’ Health Resources and Services Administration  in the Office of Pharmacy Affairs, where her work focused on the 340B Drug Pricing Program, the Patient Safety and Clinical Pharmacy Services Collaborative, and Affordable Care Act provisions related to the patient-centered medical home, care coordination during transitions of care and clinical pharmacy services. After the office restructured in 2011, she returned to Baltimore, where her work blended policy and practice to manage the successful launch of two new outpatient hospital pharmacies at LifeBridge Health. Concurrently, she was appointed by Governor Martin O'Malley to one of two health system pharmacy seats on the Maryland Board of Pharmacy.

Stephanie moved in 2012 to the DHHS’ Centers for Medicare and Medicaid Services where her work focuses on policy for the Medicare Prescription Drug Benefit (Part D). She has particular interest in the comparative economics and policy of global pharmaceutical care services delivery and, in her spare time, enjoys cooking, dancing, competing in triathlons and travelling. She can be reached at


2007 - 2008

Anna Legreid Dopp, Pharm.D.

Anna Legreid Dopp completed her Doctor of Pharmacy degree in 2002 from the University of Minnesota College of Pharmacy. Upon graduation, she began working at Medtronic, Inc., as a manager and principal training and education specialist in the Cardiac Rhythm Disease Management Core Clinical and Outcomes Research department.

In May 2005, she accepted a position as a clinical assistant professor at the University of Wisconsin School of Pharmacy in the Extension Services in Pharmacy Division. Three years later, she took a leave of absence from the University of Wisconsin and completed a Congressional Healthcare Policy Fellow Program in Washington, D.C., where she worked on health and social legislation in the office of Senator Joe Lieberman.

She has worked as a clinical pharmacist and as a medication use policy analyst at the University of Wisconsin Hospitals and Clinics as well as the Vice President of Public Affairs for the Pharmacy Society of Wisconsin and serves as the editor of the Journal of the Pharmacy Society of Wisconsin. Recently, Dopp joined the American Society of Health-System Pharmacists as the director of Clinical Guidelines and Quality Improvement.

Headshot of George Neyarapally, Pharm.D., J.D.

2006 - 2007

George Neyarapally, Pharm.D., J.D.

From 2004 to 2005, George worked as a pharmacist for PPD. In 2006, he was the Inaugural VCU/ACCP/ASHP Healthcare Policy Fellow and worked in the HHS Office of the Assistant Secretary for Preparedness and Response, the personal office of a United States Senator, and in the government affairs offices of ASHP and ACCP. From 2007 to 2008, George worked at the Agency for Healthcare Research and Quality (AHRQ) on comparative effectiveness research programs and initiatives.

From 2008 to 2014, George worked at FDA, conducting regulatory science research, contributing to guidance development, and serving on new drug and biologic application review teams. He next worked as Medicaid Pharmacy Director for New Hampshire from 2014 to 2015, during which time he led the analysis and oversight of Medicaid pharmaceutical policies and quality improvement initiatives and served on a PCORI stakeholder review panel.

From 2015 to 2021, at MITRE, the Health/HHS Federally Funded Research and Development Center (FFRDC) operator, George served as a Principal in Health and Life Sciences, leading a staff of up to eight, and as a strategic advisor, researcher, and subject matter expert on CMS alternative payment models, HHS health and pharmaceutical policy, biomedical innovation, and health data-related projects and initiatives (e.g., NIH, AHRQ, HHS/ASPE projects), and innovative MITRE HIT and policy-related initiatives. Neyarapally rejoined HHS in February of 2021 at FDA in the Center for Drug Evaluation and Research (CDER).

Neyarapally received his B.S. in Finance from the University of Connecticut, Pharm.D. from the University of North Carolina, M.P.H. from the Johns Hopkins Bloomberg School of Public Health, and J.D. from the University of Maryland.